Advisory Board

Sandip Sarkar

FRCS, MA, PhD
Specialist Clinical Advisor Woundcare

After graduating from Cambridge University, Mr Sarkar underwent medical training at the United Medical and Dental Schools of Guys and St Thomas’ in London. His higher surgical training was through the London Deanery, when he gained his Fellowship of the Royal College of Surgeons. His PhD (University College London) was awarded in Vascular surgery and his Certificate of Completion of Training in General Surgery.

He has published widely in nanocomposite compliant graft development as well as arterial tissue engineering. As a specialist Vascular and Endovascular Surgeon at The Royal London Hospital, Barts Health NHS Trust; he has established a pioneering complex diabetic foot multidisciplinary unit and has an interest in wound management and amputation avoidance.

Dr Rick Morton

B.Sc (Hons) PhD, NED
Non-Executive Director

Rick Morton is the Chief Medical Officer & Global Head of Access for VMLY&R and WPP Health Wellness and has extensive academic, biopharmaceutical industry and global healthcare experience. Passionate about the critical role of medical affairs and market access in the planning and execution of pre, peri and post-launch patient-centric strategies that guide effective value-based healthcare product development and commercialization.

Kambiz Golchin

ENT & Facial Plastic Surgeon M Med Sci,
FRCS (Eng), FRCS(ORL-HNS)
Co-founder & Consultant Specialist – Aesthetics.

Mr Kambiz Golchin graduated from Royal College of Surgeons in Ireland in 1994 and continued his surgical training in Northern Ireland. He became a Fellow of the Royal College of Surgeons of England in 1998.

Mr Golchin is a consultant ENT & Facial Plastic Surgeon. A Facial Plastic Surgeon does not perform plastic procedures below the neck, and he limits the area on which he operates. Examples of procedures performed by Facial Plastic Surgeons are facelifts, rhinoplasty, and browlifts

Read more

Dr Pete Clausen

PhD,
Scientific Advisor

Pete is currently the Chief Scientific Officer for Nuo Therapeutics Inc focused on the development of autologous stem cell technologies and the commercialization of medical devices for the orthopaedic and chronic wound markets. He has more than 25 years of experience in biotechnology having worked within both the US National Institutes of Health and the commercial biotech industry to develop small molecule, peptide and stem cell-based therapies in the areas of inflammatory mediated disease and stem cell transplantation.